Oxycodone Market Size & Share, by Route of Administration (Oral, Intravenous); Application (Analgesic, Sedative); End-user (Hospitals, Oncological Centers, Drug Stores) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 3794
  • Published Date: Apr 03, 2023
  • Report Format: PDF, PPT

Companies Dominating the Oxycodone Landscape

top-features-companies
    • Nektar Therapeutics
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Thermo Fisher Scientific Inc.
    • Boehringer Ingelheim GmbH
    • Bayer AG
    • Abbott Laboratories
    • Merck & Co., Inc.
    • Esteve Pharmaceuticals, S.A.
    • Validus Pharmaceuticals LLC
    • Teva Pharmaceutical Industries Ltd.
    • Siemens Healthcare GmbH

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • The Anesthetics and Analgesics Products Advisory Committee, FDA, and Drug Safety and Risk Management Advisory Committee discuss the use of oxycodegol, a new oxycodone-based drug, to treat chronic low back pain in adult patients.

  • FDA creates an opioid system model to overlook and highlight potential opioid drug use, misuse, and abuse.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 3794
  • Published Date: Apr 03, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing incidences of cancer and the growing oncology spending are the major factors driving the growth of the oxycodone market.

The market is anticipated to attain a CAGR of ~7% over the forecast period, i.e., 2023-2035.

The side effects and addictive nature of opioids are the challenges affecting the market growth.

The market in Asia Pacific is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Bayer AG, Abbott Laboratories, Merck & Co., Inc., Validus Pharmaceuticals LLC, Teva Pharmaceutical Industries Ltd., Siemens Healthcare GmbH., and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by route of administration, end user, application, and by region

The oral segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying